These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30686085)

  • 1. Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease.
    Santer L; López B; Ravassa S; Baer C; Riedel I; Chatterjee S; Moreno MU; González A; Querejeta R; Pinet F; Thum T; Díez J
    Hypertension; 2019 Apr; 73(4):820-828. PubMed ID: 30686085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial.
    Meessen JMTA; Bär C; di Dona FM; Staszewsky LI; Di Giulio P; Di Tano G; Costa A; Leonardy J; Novelli D; Nicolis EB; Masson S; Pinet F; Thum T; Latini R
    Clin Chem; 2021 Nov; 67(12):1721-1731. PubMed ID: 34751777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction.
    Yan L; Zhang Y; Wang M; Wang L; Zhang W; Ge ZR
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2589-2594. PubMed ID: 34365838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.
    Kumarswamy R; Bauters C; Volkmann I; Maury F; Fetisch J; Holzmann A; Lemesle G; de Groote P; Pinet F; Thum T
    Circ Res; 2014 May; 114(10):1569-75. PubMed ID: 24663402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.
    O'Meara E; Rouleau JL; White M; Roy K; Blondeau L; Ducharme A; Neagoe PE; Sirois MG; Lavoie J; Racine N; Liszkowski M; Madore F; Tardif JC; de Denus S;
    Circ Heart Fail; 2014 Sep; 7(5):773-81. PubMed ID: 25027873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
    Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations among co-morbidity, cardiac geometries and mechanics in hospitalized heart failure with or without preserved ejection fraction.
    Lo CI; Lai YH; Chang SN; Kuo JY; Hsieh YC; Bulwer BE; Hung CL; Yeh HI
    Clin Exp Hypertens; 2017; 39(5):473-480. PubMed ID: 28569600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
    Ravassa S; Beaumont J; Cediel G; Lupón J; López B; Querejeta R; Díez J; Bayés-Genís A; González A
    Rev Esp Cardiol (Engl Ed); 2020 Oct; 73(10):835-843. PubMed ID: 31948893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.
    Imazu M; Takahama H; Asanuma H; Funada A; Sugano Y; Ohara T; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1504-11. PubMed ID: 25217649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
    Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
    J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
    Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
    Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
    Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Circulating Extracellular RNAs With Myocardial Remodeling and Heart Failure.
    Shah RV; Rong J; Larson MG; Yeri A; Ziegler O; Tanriverdi K; Murthy V; Liu X; Xiao C; Pico AR; Huan T; Levy D; Lewis GD; Rosenzweig A; Vasan RS; Das S; Freedman JE
    JAMA Cardiol; 2018 Sep; 3(9):871-876. PubMed ID: 30090932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.